Boston Scientific (BSX) Tops Q3 EPS by 12c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $45.97 -3.83%
Revenue Growth %: +3.7%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.7%
Financial Fact:
Interest expense: -58M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.37, $0.12 better than the analyst estimate of $0.25. Revenue for the quarter came in at $2.67 billion versus the consensus estimate of $2.52 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
- Boston Scientific unlikely to meet forecasts after cyber attack - Bloomberg
- HSBC lifts S&P 500 year-end target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
